CIBC World Market’s Aptose Biosciences, Inc. APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-27
Closed -$17K 1405
2022
Q1
$17K Buy
+27
New +$14.9K ﹤0.01% 1289

Other funds holding APTO

CIBC World Market's APTO Position: Q2 2022 in Review

CIBC World Market sold out of Aptose Biosciences, Inc. (APTO) in Q2 2022, closing a stake of 27 shares — an estimated $17K sold.

CIBC World Market first reported a position in APTO in Q1 2022 and held it in 1 quarter. The position peaked at $17K in Q1 2022. 48 funds tracked by Wall St. Rank hold APTO as of Q2 2022.

  • CIBC World Market reported no remaining Aptose Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
  • CIBC World Market sold 27 Aptose Biosciences, Inc. shares in Q2 2022, an estimated $17K.
  • CIBC World Market first reported a position in Aptose Biosciences, Inc. in Q1 2022 and held it in 1 quarter.
  • CIBC World Market's Aptose Biosciences, Inc. position peaked at $17K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2022.

Based on CIBC World Market's 13F filing for Q2 2022, filed 10 Aug 2022.